サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1463133

検体妥当性試験市場、シェア、規模、動向、産業分析レポート：タイプ別、製品・サービス別、薬物タイプ別、適応症別、エンドユーザー別、地域別、セグメント予測、2024年～2032年

Specimen Validity Testing Market Share, Size, Trends, Industry Analysis Report, By Type (Laboratory Testing, Rapid/POC Testing); By Product & Service; By Drug Type; By Indication; By End User; By Region; Segment Forecast, 2024 - 2032
出版日: | 発行: Polaris Market Research | ページ情報: 英文 119 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.91円
検体妥当性試験市場、シェア、規模、動向、産業分析レポート：タイプ別、製品・サービス別、薬物タイプ別、適応症別、エンドユーザー別、地域別、セグメント予測、2024年～2032年
出版日: 2024年03月24日
発行: Polaris Market Research
ページ情報: 英文 119 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、検体妥当性試験の世界市場規模は2032年までに25億2,000万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

世界レベルでの乱用検査ニーズの高まりが、検体妥当性試験市場の成長を大きく後押ししています。検体妥当性試験で個人の薬物摂取やその他の食物摂取を特定できる可能性が、法律や法医学活動での採用を促進しています。検体の改ざんが著しく増加し、尿検体のセキュリティと安全性に対する懸念が高まっていることから、検体妥当性試験ツールで検体の完全性をチェックすることが法執行官に奨励されています。

不純物混入、希釈、改ざんを判定する機能は、職場、薬物検査、刑事司法システム、および世界マーケットの他のセクターで採用された主な要因です。不正確な薬物検査結果は多くの人々に危害を及ぼす可能性があるため、薬物検査の信頼性を判定するための医学的検査に対する需要が高まっています。

検体妥当性試験は、航空機、鉄道、自動車運送業者、その他の交通機関のような、規制された部門の微妙な場所にいる個人に対して広く実施されています。国民の安全を守るために効果的な薬物検査ツールを採用する政府の取り組みは、市場の成長を促進すると思われます。例えば、2023年5月、運輸省（DOT）は尿検査に代わるものとして経口薬物検査を導入しました。

職場や輸送における安全性を向上させるための世界の厳しい規制は、検体の有効性検査に多様な機会を生み出すと予想されます。さらに、現在進行中の調査研究では、合成尿を判定し、新たな検体妥当性試験を創出するための潜在的技術が模索されています。例えば、WILEY誌に掲載された2023年の研究では、検体操作検査に関するレビューが行われました。

検体妥当性試験市場レポートハイライト

尿検査サービスを提供する検査室数の増加により、検査室検査分野が最も高い成長が見込まれます。

製品セグメントは、尿検査活動の継続的なニーズにより、最大の市場シェアを占めています。

抗ウイルス薬セグメントは、ウイルス感染症の流行により、より大きな収益シェアを占めると予測されています。

アジア太平洋地域では、薬物スクリーニング検査の数が増加しているため、予測期間中に最も速い成長を記録すると予測されています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の検体妥当性試験市場の洞察

  • 検体妥当性試験- 業界スナップショット
  • 標本妥当性試験市場力学
    • 促進要因と機会
      • 薬物使用を緩和するための政府規制の強化
      • 違法薬物の使用の増加
    • 抑制要因と課題
      • 代替薬物スクリーニング検査に関する意識の高まり
  • PESTLE分析
  • 検体妥当性試験業界の動向
  • COVID-19の影響分析

第5章 世界の検体妥当性試験市場、タイプ別

  • 主な調査結果
  • イントロダクション
  • 臨床検査
  • 迅速/POCテスト

第6章 世界の検体妥当性試験市場、適応症別

  • 主な調査結果
  • イントロダクション
  • 血流感染症
  • 尿路感染症
  • 手術部位感染
  • 肺炎
  • その他

第7章 世界の検体妥当性試験市場、製品・サービス別

  • 主な調査結果
  • イントロダクション
  • 製品
  • サービス

第8章 世界の検体妥当性試験市場、薬剤タイプ別

  • 主な調査結果
  • イントロダクション
  • 抗菌薬
  • 抗真菌薬
  • 抗ウイルス薬
  • その他

第9章 世界の検体妥当性試験市場、エンドユーザー別

  • 主な調査結果
  • イントロダクション
  • 薬物スクリーニング研究所
  • 疼痛管理センター
  • 薬物リハビリセンター
  • 職場
  • その他

第10章 世界の検体妥当性試験市場、地域別

  • 主な調査結果
  • イントロダクション
    • 検体妥当性試験市場評価、地域、2019-2032年
  • 検体妥当性試験市場-北米
    • 北米：検体妥当性試験市場、タイプ別、2019年～2032年
    • 北米：検体妥当性試験市場、薬剤タイプ別、2019年～2032年
    • 北米：検体妥当性試験市場、適応症別、2019年～2032年
    • 北米：検体妥当性試験市場、製品・サービス別、2019年～2032年
    • 北米：検体妥当性試験市場、エンドユーザー別、2019年～2032年
    • 検体妥当性試験市場-米国
    • 検体妥当性試験市場- カナダ
  • 検体妥当性試験市場- 欧州
    • 欧州：検体妥当性試験市場、タイプ別、2019-2032年
    • 欧州：検体妥当性試験市場、薬剤タイプ別、2019年～2032年
    • 欧州：検体妥当性試験市場、適応症別、2019年～2032年
    • 欧州：検体妥当性試験市場、製品・サービス別、2019年～2032年
    • 欧州：検体妥当性試験市場、エンドユーザー別、2019年～2032年
    • 検体妥当性試験市場- 英国
    • 検体妥当性試験市場- フランス
    • 検体妥当性試験市場- ドイツ
    • 検体妥当性試験市場- イタリア
    • 検体妥当性試験市場- スペイン
    • 検体妥当性試験市場- オランダ
    • 検体妥当性試験市場- ロシア
  • 検体妥当性試験市場- アジア太平洋地域
    • アジア太平洋地域：検体妥当性試験市場、タイプ別、2019年～2032年
    • アジア太平洋地域：検体妥当性試験市場、薬剤タイプ別、2019年～2032年
    • アジア太平洋地域：検体妥当性試験市場、適応症別、2019年～2032年
    • アジア太平洋地域：検体妥当性試験市場、製品・サービス別、2019年～2032年
    • アジア太平洋地域：検体妥当性試験市場、エンドユーザー別、2019年～2032年
    • 検体妥当性試験市場- 中国
    • 検体妥当性試験市場- インド
    • 検体妥当性試験市場- 日本
    • 検体妥当性試験市場- マレーシア
    • 検体妥当性試験市場- インドネシア
    • 検体妥当性試験市場- 韓国
  • 検体妥当性試験市場-中東およびアフリカ
    • 中東およびアフリカ：検体妥当性試験市場、タイプ別、2019-2032年
    • 中東およびアフリカ：検体妥当性試験市場、薬剤タイプ別、2019-2032年
    • 中東およびアフリカ：検体妥当性試験市場、適応症別、2019-2032年
    • 中東およびアフリカ：検体妥当性試験市場、製品およびサービス別、2019-2032年
    • 中東およびアフリカ：検体妥当性試験市場、エンドユーザー別、2019-2032年
    • 検体妥当性試験市場- サウジアラビア
    • 検体妥当性試験市場-UAE
    • 検体妥当性試験市場- イスラエル
    • 検体妥当性試験市場- 南アフリカ
  • 検体妥当性試験市場-ラテンアメリカ
    • ラテンアメリカ：検体妥当性試験市場、タイプ別、2019年～2032年
    • ラテンアメリカ：検体妥当性試験市場、薬剤タイプ別、2019年～2032年
    • ラテンアメリカ：検体妥当性試験市場、適応症別、2019年～2032年
    • ラテンアメリカ：検体妥当性試験市場、製品・サービス別、2019年～2032年
    • ラテンアメリカ：検体妥当性試験市場、エンドユーザー別、2019年～2032年
    • 検体妥当性試験市場- メキシコ
    • 検体妥当性試験市場- ブラジル
    • 検体妥当性試験市場- アルゼンチン

第11章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • パートナーシップ/コラボレーション/契約/公開

第12章 企業プロファイル

  • Abbott（US）
  • Alfa Scientific Designs（US）
  • Healgen Scientific LLC（US）
  • LabCorp（US）
  • Nona Scientific Laboratory（US）
  • Omega Laboratories（Canada）
  • Premier Biotech, Inc.（US）
  • Quest Diagnostics（US）
  • Rochester Regional Health（US）
  • Sciteck, Inc.（US）
  • Siemens Healthineers（Germany）
  • Thermo Fisher Scientific（US）
  • Vision Diagnostics, Inc.（India）
図表

List of Tables

  • Table 1 Global Specimen Validity Testing Market, by Type, by Region, 2019-2032 (USD Billion)
  • Table 2 Global Specimen Validity Testing Market, by Indication, by Region, 2019-2032 (USD Billion)
  • Table 3 Global Specimen Validity Testing Market, by Product & Services, by Region, 2019-2032 (USD Billion)
  • Table 4 Global Specimen Validity Testing Market, by End-User, by Region, 2019-2032 (USD Billion)
  • Table 5 Global Specimen Validity Testing Market, by Drug Type, by Region, 2019-2032 (USD Billion)
  • Table 6 North America: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
  • Table 7 North America: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
  • Table 8 North America: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
  • Table 9 North America: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
  • Table 10 North America: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 11 U.S.: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
  • Table 12 U.S.: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
  • Table 13 U.S.: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
  • Table 14 U.S.: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
  • Table 15 U.S.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 16 Canada: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
  • Table 17 Canada: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
  • Table 18 Canada: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
  • Table 19 Canada: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
  • Table 20 Canada: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 21 Europe: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
  • Table 22 Europe: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
  • Table 23 Europe: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
  • Table 24 Europe: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
  • Table 25 Europe: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 26 Germany: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
  • Table 27 Germany: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
  • Table 28 Germany: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
  • Table 29 Germany: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
  • Table 30 Germany: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 31 France: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
  • Table 32 France: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
  • Table 33 France: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
  • Table 34 France: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
  • Table 35 France: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 36 UK: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
  • Table 37 UK: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
  • Table 38 UK: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
  • Table 39 UK: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
  • Table 40 UK: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 41 Italy: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
  • Table 42 Italy: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
  • Table 43 Italy: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
  • Table 44 Italy: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
  • Table 45 Italy: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 46 Netherlands: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
  • Table 47 Netherlands: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
  • Table 48 Netherlands: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
  • Table 49 Netherlands: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
  • Table 50 Netherlands: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 51 Spain: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
  • Table 52 Spain: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
  • Table 53 Spain: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
  • Table 54 Spain: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
  • Table 55 Spain: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 56 Russia: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
  • Table 57 Russia: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
  • Table 58 Russia: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
  • Table 59 Russia: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
  • Table 60 Russia: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 61 Asia Pacific: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
  • Table 62 Asia Pacific: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
  • Table 63 Asia Pacific: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
  • Table 64 Asia Pacific: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
  • Table 65 Asia Pacific: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 66 China: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
  • Table 67 China: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
  • Table 68 China: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
  • Table 69 China: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
  • Table 70 China: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 71 Japan: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
  • Table 72 Japan: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
  • Table 73 Japan: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
  • Table 74 Japan: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
  • Table 75 Japan: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 76 India: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
  • Table 77 India: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
  • Table 78 India: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
  • Table 79 India: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
  • Table 80 India: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 81 Indonesia: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
  • Table 82 Indonesia: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
  • Table 83 Indonesia: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
  • Table 84 Indonesia: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
  • Table 85 Indonesia: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 86 Malaysia: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
  • Table 87 Malaysia: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
  • Table 88 Malaysia: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
  • Table 89 Malaysia: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
  • Table 90 Malaysia: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 91 South Korea: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
  • Table 92 South Korea: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
  • Table 93 South Korea: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
  • Table 94 South Korea: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
  • Table 95 South Korea: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 96 Latin America: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
  • Table 97 Latin America: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
  • Table 98 Latin America: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
  • Table 99 Latin America: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
  • Table 100 Latin America: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 101 Brazil: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
  • Table 102 Brazil: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
  • Table 103 Brazil: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
  • Table 104 Brazil: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
  • Table 105 Brazil: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 106 Mexico: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
  • Table 107 Mexico: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
  • Table 108 Mexico: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
  • Table 109 Mexico: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
  • Table 110 Mexico: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 111 Argentina: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
  • Table 112 Argentina: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
  • Table 113 Argentina: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
  • Table 114 Argentina: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
  • Table 115 Argentina: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 116 Middle East & Africa: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
  • Table 117 Middle East & Africa: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
  • Table 118 Middle East & Africa: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
  • Table 119 Middle East & Africa: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
  • Table 120 Middle East & Africa: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 121 UAE: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
  • Table 122 UAE: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
  • Table 123 UAE: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
  • Table 124 UAE: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
  • Table 125 UAE: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 126 Saudi Arabia: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
  • Table 127 Saudi Arabia: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
  • Table 128 Saudi Arabia: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
  • Table 129 Saudi Arabia: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
  • Table 130 Saudi Arabia: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 131 South Africa: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
  • Table 132 South Africa: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
  • Table 133 South Africa: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
  • Table 134 South Africa: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
  • Table 135 South Africa: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 136 Israel: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
  • Table 137 Israel: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
  • Table 138 Israel: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
  • Table 139 Israel: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
  • Table 140 Israel: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Specimen Validity Testing Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global Specimen Validity Testing Market, by Type, 2021 & 2030 (USD Billion)
  • Figure 8. Market by Indication
  • Figure 9. Global Specimen Validity Testing Market, by Indication, 2021 & 2030 (USD Billion)
  • Figure 10. Market by Product & Services
  • Figure 11. Global Specimen Validity Testing Market, by Product & Services, 2021 & 2030 (USD Billion)
  • Figure 12. Market by End-User
  • Figure 13. Global Specimen Validity Testing Market, by End-User, 2021 & 2030 (USD Billion)
  • Figure 14. Market by Drug Type
  • Figure 15. Global Specimen Validity Testing Market, by Drug Type, 2021 & 2030 (USD Billion)
目次
Product Code: PM4792

The global specimen validity testing market size is expected to reach USD 2.52 billion by 2032, according to a new study by Polaris Market Research. The report "Specimen Validity Testing Market Share, Size, Trends, Industry Analysis Report, By Type (Laboratory Testing, Rapid/POC Testing); By Product & Service; By Drug Type; By Indication; By End User; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising need for abuse testing at the global level highly drives the growth of the specimen validity testing market. The potential to identify the individual's drug intake and other food intake with specimen validity testing is facilitating its adoption in legal and forensic science activities. The significant rise in sample tampering and growing concerns about the security and safety of urine samples encouraged legal officers to check the integrity of the sample with specimen validity testing tools.

The capability to determine adulteration, dilution, and tampering is the primary factor contributing to its adoption in the workplace, drug testing, criminal justice system, and other sectors of the global marketplace. As incorrect drug test results can cause harm to several people, there is increasing demand for medical tests to determine the reliability of the drug tests.

Specimen validity testing is widely conducted on individuals in sensitive places in the regulated sector, such as airplanes, rail, motor carriers, and other transits. The government's initiatives to adopt effective drug testing tools to safeguard the population are likely to propel market growth. For instance, in May 2023, the Department of Transportation (DOT) introduced oral drug testing as an alternative to urine testing.

Stringent regulations globally to improve safety at the workplace and in transportation are anticipated to create diverse opportunities for specimen validity testing. Furthermore, ongoing research studies are exploring potential technologies to determine synthetic urine and create new specimen validity testing. For instance, a 2023 study published in WILEY magazine conducted a review on sample manipulation testing.

Specimen Validity Testing Market Report Highlights

The laboratory testing segment is anticipated to witness the highest growth due to the growing number of laboratories providing urine testing services.

The products segment accounted for the largest market share owing to the continuous need for urine testing activities.

The antiviral drugs segment is projected to experience a larger revenue share due to the prevalence of viral infections.

Asia Pacific is projected to register the fastest growth during the forecast period due to the rising number of drug screening tests in the region.

The global players include Abbott, Alfa Scientific Designs, Healgen Scientific, LabCorp, Nona Scientific Laboratory, Omega Laboratories, & Premier Biotech.

Polaris Market Research has segmented the specimen validity testing market report based on product & service, type, drug type, indication, end user and region:

Specimen Validity Testing, Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Laboratory Testing
  • Rapid/POC Testing

Specimen Validity Testing, Product & Service Outlook (Revenue - USD Billion, 2019 - 2032)

  • Products
  • Assay Kits
  • Reagents and Calibrators
  • Disposables
  • Services

Specimen Validity Testing, Drug Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Antibacterial Drugs
  • Antifungal Drugs
  • Antiviral Drugs
  • Others

Specimen Validity Testing, Indication Outlook (Revenue - USD Billion, 2019 - 2032)

  • Bloodstream Infections
  • Urinary Tract Infections
  • Surgical Site Infections
  • Pneumonia
  • Others

Specimen Validity Testing, End User Outlook (Revenue - USD Billion, 2019 - 2032)

  • Drug Screening Laboratories
  • Pain Management Centers
  • Drug Rehabilitation Centre
  • Workplace
  • Others

Specimen Validity Testing, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Specimen Validity Testing Market Insights

  • 4.1. Specimen Validity Testing - Industry Snapshot
  • 4.2. Specimen Validity Testing Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising government regulations to mitigate drug use
      • 4.2.1.2. Increased use of illegal drugs
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Growing awareness about the alternative drug screening tests
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Specimen Validity Testing Industry Trends
  • 4.6. COVID-19 Impact Analysis

5. Global Specimen Validity Testing Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
  • 5.3. Laboratory Testing
    • 5.3.1. Global Specimen Validity Testing Market, by Laboratory Testing, by Region, 2019-2032 (USD Billion)
  • 5.4. Rapid/POC Testing
    • 5.4.1. Global Specimen Validity Testing Market, by Rapid/POC Testing, by Region, 2019-2032 (USD Billion)

6. Global Specimen Validity Testing Market, by Indication

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
  • 6.3. Bloodstream Infections
    • 6.3.1. Global Specimen Validity Testing Market, by Bloodstream Infections, by Region, 2019-2032 (USD Billion)
  • 6.4. Urinary Tract Infections
    • 6.4.1. Global Specimen Validity Testing Market, by Urinary Tract Infections, by Region, 2019-2032 (USD Billion)
  • 6.5. Surgical Site Infections
    • 6.5.1. Global Specimen Validity Testing Market, by Surgical Site Infections, by Region, 2019-2032 (USD Billion)
  • 6.6. Pneumonia
    • 6.6.1. Global Specimen Validity Testing Market, by Pneumonia, by Region, 2019-2032 (USD Billion)
  • 6.7. Others
    • 6.7.1. Global Specimen Validity Testing Market, by Others, by Region, 2019-2032 (USD Billion)

7. Global Specimen Validity Testing Market, by Product & Services

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
  • 7.3. Products
    • 7.3.1. Global Specimen Validity Testing Market, by Products, by Region, 2019-2032 (USD Billion)
    • 7.3.2. Assay Kits
      • 7.3.2.1. Global Specimen Validity Testing Market, by Assay Kits, by Region, 2019-2032 (USD Billion)
    • 7.3.3. Reagents and Calibrators
      • 7.3.3.1. Global Specimen Validity Testing Market, by Reagents and Calibrators, by Region, 2019-2032 (USD Billion)
    • 7.3.4. Disposables
      • 7.3.4.1. Global Specimen Validity Testing Market, by Disposables, by Region, 2019-2032 (USD Billion)
  • 7.4. Services
    • 7.4.1. Global Specimen Validity Testing Market, by Services, by Region, 2019-2032 (USD Billion)

8. Global Specimen Validity Testing Market, by Drug Type

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
  • 8.3. Antibacterial Drugs
    • 8.3.1. Global Specimen Validity Testing Market, by Antibacterial Drugs, by Region, 2019-2032 (USD Billion)
  • 8.4. Antifungal Drugs
    • 8.4.1. Global Specimen Validity Testing Market, by Antifungal Drugs, by Region, 2019-2032 (USD Billion)
  • 8.5. Antiviral Drugs
    • 8.5.1. Global Specimen Validity Testing Market, by Antiviral Drugs, by Region, 2019-2032 (USD Billion)
  • 8.6. Others
    • 8.6.1. Global Specimen Validity Testing Market, by Others, by Region, 2019-2032 (USD Billion)

9. Global Specimen Validity Testing Market, by End-User

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
  • 9.3. Drug Screening Laboratories
    • 9.3.1. Global Specimen Validity Testing Market, by Drug Screening Laboratories, by Region, 2019-2032 (USD Billion)
  • 9.4. Pain Management Centers
    • 9.4.1. Global Specimen Validity Testing Market, by Pain Management Centers, by Region, 2019-2032 (USD Billion)
  • 9.5. Drug Rehabilitation Centre
    • 9.5.1. Global Specimen Validity Testing Market, by Drug Rehabilitation Centre, by Region, 2019-2032 (USD Billion)
  • 9.6. Workplace
    • 9.6.1. Global Specimen Validity Testing Market, by Workplace, by Region, 2019-2032 (USD Billion)
  • 9.7. Others
    • 9.7.1. Global Specimen Validity Testing Market, by Others, by Region, 2019-2032 (USD Billion)

10. Global Specimen Validity Testing Market, by Geography

  • 10.1. Key findings
  • 10.2. Introduction
    • 10.2.1. Specimen Validity Testing Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 10.3. Specimen Validity Testing Market - North America
    • 10.3.1. North America: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
    • 10.3.2. North America: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
    • 10.3.3. North America: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
    • 10.3.4. North America: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
    • 10.3.5. North America: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
    • 10.3.6. Specimen Validity Testing Market - U.S.
      • 10.3.6.1. U.S.: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
      • 10.3.6.2. U.S.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.3.6.3. U.S.: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
      • 10.3.6.4. U.S.: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
      • 10.3.6.5. U.S.: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
    • 10.3.7. Specimen Validity Testing Market - Canada
      • 10.3.7.1. Canada: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
      • 10.3.7.2. Canada.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.3.7.3. Canada: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
      • 10.3.7.4. Canada: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
      • 10.3.7.5. Canada: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
  • 10.4. Specimen Validity Testing Market - Europe
    • 10.4.1. Europe: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
    • 10.4.2. Europe.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
    • 10.4.3. Europe: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
    • 10.4.4. Europe: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
    • 10.4.5. Europe: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
    • 10.4.6. Specimen Validity Testing Market - UK
      • 10.4.6.1. UK: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
      • 10.4.6.2. UK.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.4.6.3. UK: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
      • 10.4.6.4. UK: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
      • 10.4.6.5. UK: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
    • 10.4.7. Specimen Validity Testing Market - France
      • 10.4.7.1. France: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
      • 10.4.7.2. France.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.4.7.3. France: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
      • 10.4.7.4. France: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
      • 10.4.7.5. France: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
    • 10.4.8. Specimen Validity Testing Market - Germany
      • 10.4.8.1. Germany: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
      • 10.4.8.2. Germany.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.4.8.3. Germany: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
      • 10.4.8.4. Germany: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
      • 10.4.8.5. Germany: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
    • 10.4.9. Specimen Validity Testing Market - Italy
      • 10.4.9.1. Italy: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
      • 10.4.9.2. Italy.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.4.9.3. Italy: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
      • 10.4.9.4. Italy: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
      • 10.4.9.5. Italy: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
    • 10.4.10. Specimen Validity Testing Market - Spain
      • 10.4.10.1. Spain: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
      • 10.4.10.2. Spain.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.4.10.3. Spain: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
      • 10.4.10.4. Spain: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
      • 10.4.10.5. Spain: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
    • 10.4.11. Specimen Validity Testing Market - Netherlands
      • 10.4.11.1. Netherlands: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
      • 10.4.11.2. Netherlands.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.4.11.3. Netherlands: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
      • 10.4.11.4. Netherlands: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
      • 10.4.11.5. Netherlands: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
    • 10.4.12. Specimen Validity Testing Market - Russia
      • 10.4.12.1. Russia: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
      • 10.4.12.2. Russia.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.4.12.3. Russia: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
      • 10.4.12.4. Russia: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
      • 10.4.12.5. Russia: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
  • 10.5. Specimen Validity Testing Market - Asia Pacific
    • 10.5.1. Asia Pacific: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
    • 10.5.2. Asia Pacific.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
    • 10.5.3. Asia Pacific: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
    • 10.5.4. Asia Pacific: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
    • 10.5.5. Asia Pacific: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
    • 10.5.6. Specimen Validity Testing Market - China
      • 10.5.6.1. China: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
      • 10.5.6.2. China.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.5.6.3. China: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
      • 10.5.6.4. China: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
      • 10.5.6.5. China: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
    • 10.5.7. Specimen Validity Testing Market - India
      • 10.5.7.1. India: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
      • 10.5.7.2. India.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.5.7.3. India: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
      • 10.5.7.4. India: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
      • 10.5.7.5. India: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
    • 10.5.8. Specimen Validity Testing Market - Japan
      • 10.5.8.1. Japan: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
      • 10.5.8.2. Japan.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.5.8.3. Japan: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
      • 10.5.8.4. Japan: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
      • 10.5.8.5. Japan: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
    • 10.5.9. Specimen Validity Testing Market - Malaysia
      • 10.5.9.1. Malaysia: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
      • 10.5.9.2. Malaysia.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.5.9.3. Malaysia: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
      • 10.5.9.4. Malaysia: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
      • 10.5.9.5. Malaysia: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
    • 10.5.10. Specimen Validity Testing Market - Indonesia
      • 10.5.10.1. Indonesia: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
      • 10.5.10.2. Indonesia.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.5.10.3. Indonesia: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
      • 10.5.10.4. Indonesia: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
      • 10.5.10.5. Indonesia: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
    • 10.5.11. Specimen Validity Testing Market - South Korea
      • 10.5.11.1. South Korea: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
      • 10.5.11.2. South Korea.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.5.11.3. South Korea: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
      • 10.5.11.4. South Korea: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
      • 10.5.11.5. South Korea: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
  • 10.6. Specimen Validity Testing Market - Middle East & Africa
    • 10.6.1. Middle East & Africa: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
    • 10.6.2. Middle East & Africa: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
    • 10.6.3. Middle East & Africa: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
    • 10.6.4. Middle East & Africa: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
    • 10.6.5. Middle East & Africa: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
    • 10.6.6. Specimen Validity Testing Market - Saudi Arabia
      • 10.6.6.1. Saudi Arabia: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
      • 10.6.6.2. Saudi Arabia.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.6.6.3. Saudi Arabia: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
      • 10.6.6.4. Saudi Arabia: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
      • 10.6.6.5. Saudi Arabia: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
    • 10.6.7. Specimen Validity Testing Market - UAE
      • 10.6.7.1. UAE: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
      • 10.6.7.2. UAE.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.6.7.3. UAE: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
      • 10.6.7.4. UAE: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
      • 10.6.7.5. UAE: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
    • 10.6.8. Specimen Validity Testing Market - Israel
      • 10.6.8.1. Israel: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
      • 10.6.8.2. Israel.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.6.8.3. Israel: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
      • 10.6.8.4. Israel: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
      • 10.6.8.5. Israel: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
    • 10.6.9. Specimen Validity Testing Market - South Africa
      • 10.6.9.1. South Africa: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
      • 10.6.9.2. South Africa.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.6.9.3. South Africa: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
      • 10.6.9.4. South Africa: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
      • 10.6.9.5. South Africa: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
  • 10.7. Specimen Validity Testing Market - Latin America
    • 10.7.1. Latin America: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
    • 10.7.2. Latin America.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
    • 10.7.3. Latin America: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
    • 10.7.4. Latin America: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
    • 10.7.5. Latin America: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
    • 10.7.6. Specimen Validity Testing Market - Mexico
      • 10.7.6.1. Mexico: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
      • 10.7.6.2. Mexico.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.7.6.3. Mexico: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
      • 10.7.6.4. Mexico: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
      • 10.7.6.5. Mexico: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
    • 10.7.7. Specimen Validity Testing Market - Brazil
      • 10.7.7.1. Brazil: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
      • 10.7.7.2. Brazil.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.7.7.3. Brazil: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
      • 10.7.7.4. Brazil: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
      • 10.7.7.5. Brazil: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
    • 10.7.8. Specimen Validity Testing Market - Argentina
      • 10.7.8.1. Argentina: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
      • 10.7.8.2. Argentina.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.7.8.3. Argentina: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
      • 10.7.8.4. Argentina: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
      • 10.7.8.5. Argentina: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)

11. Competitive Landscape

  • 11.1. Expansion and Acquisition Analysis
    • 11.1.1. Expansion
    • 11.1.2. Acquisitions
  • 11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

  • 12.1. Abbott (US)
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Benchmarking
    • 12.1.4. Recent Development
  • 12.2. Alfa Scientific Designs (US)
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Benchmarking
    • 12.2.4. Recent Development
  • 12.3. Healgen Scientific LLC (US)
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Benchmarking
    • 12.3.4. Recent Development
  • 12.4. LabCorp (US)
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Benchmarking
    • 12.4.4. Recent Development
  • 12.5. Nona Scientific Laboratory (US)
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Benchmarking
    • 12.5.4. Recent Development
  • 12.6. Omega Laboratories (Canada)
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Benchmarking
    • 12.6.4. Recent Development
  • 12.7. Premier Biotech, Inc. (US)
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Benchmarking
    • 12.7.4. Recent Development
  • 12.8. Quest Diagnostics (US)
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Benchmarking
    • 12.8.4. Recent Development
  • 12.9. Rochester Regional Health (US)
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Benchmarking
    • 12.9.4. Recent Development
  • 12.10. Sciteck, Inc. (US)
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Benchmarking
    • 12.10.4. Recent Development
  • 12.11. Siemens Healthineers (Germany)
    • 12.11.1. Company Overview
    • 12.11.2. Financial Performance
    • 12.11.3. Product Benchmarking
    • 12.11.4. Recent Development
  • 12.12. Thermo Fisher Scientific (US)
    • 12.12.1. Company Overview
    • 12.12.2. Financial Performance
    • 12.12.3. Product Benchmarking
    • 12.12.4. Recent Development
  • 12.13. Vision Diagnostics, Inc. (India)
    • 12.13.1. Company Overview
    • 12.13.2. Financial Performance
    • 12.13.3. Product Benchmarking
    • 12.13.4. Recent Development